$30 million invested in new pharmaceutical production facility in Herat

A significant investment of $30 million has been announced for the establishment of a new pharmaceutical production facility in Herat, Afghanistan. This initiative aims to enhance the local pharmaceutical industry by increasing the production capacity of essential medicines. The facility is expected to create numerous job opportunities for the local workforce and contribute to the overall economic development of the region. Officials have highlighted the importance of local production in reducing dependency on imported pharmaceuticals and improving healthcare access for the population. The investment reflects a growing commitment to strengthening Afghanistan's healthcare infrastructure and supporting sustainable development initiatives within the country.